The major strength of the YSPORE is the outstanding scientific faculty and clinical investigators and its clinical and basic research resources. The faculty includes over 60 investigators with diverse interests drawn from basic, clinical and population science departments at Yale (Dermatology, Yale Comprehensive Cancer Center/Oncology, Pathology, Surgery, Genetics, Immunology, Epidemiology, Biostatistics, Laboratory Medicine, Chemical & Biomedical Engineering, Therapeutic Radiology, Molecular, Cellular, and Developmental Biology) and outside Yale (Cell Biology, New York University, NY). There is a wide spread expertise in basic and clinical aspects of melanoma, non-melanoma skin cancers, molecular biology, approaches for genome and proteome wide analysis, immunology, oncology, surgery, biostatistics, bioinformatics, behavioral sciences, pathology and dermatopathology. As a group, the investigators are interested in cancer research - over 90% of the Yale investigators are members of the Yale Comprehensive Cancer Center.
The YSPORE is overseen by internal and external board of advisors composed of distinguished investigators with expertise in translational research. The board meets once a year to evaluate the program, and to provide criticism and suggestion to changes. The YSPORE is flexible, and can change direction to ensure excellence, progress and translational results.